These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34857588)

  • 1. Primary nasal epithelial cells from patients with cystic fibrosis hold promise for guiding precision medicine and expanding treatment.
    Reeves SR
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34857588
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making precision medicine personal for cystic fibrosis.
    Manfredi C; Tindall JM; Hong JS; Sorscher EJ
    Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine for cystic fibrosis: establishing human model systems.
    Mou H; Brazauskas K; Rajagopal J
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S14-23. PubMed ID: 26335952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal epithelial cells as a gold-standard predictive model for personalized medicine in cystic fibrosis.
    Pedemonte N
    J Physiol; 2022 Mar; 600(6):1285-1286. PubMed ID: 35038767
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost of precision medicine at a referral center for cystic fibrosis.
    Marson FAL
    J Bras Pneumol; 2020 Mar; 46(2):e20190308. PubMed ID: 32130336
    [No Abstract]   [Full Text] [Related]  

  • 7. [Challenges of personalized medicine for cystic fibrosis].
    Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
    Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.
    Keegan DE; Brewington JJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalised medicine for cystic fibrosis: treating the basic defect.
    Elborn JS
    Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent progress in translational cystic fibrosis research using precision medicine strategies.
    Cholon DM; Gentzsch M
    J Cyst Fibros; 2018 Mar; 17(2S):S52-S60. PubMed ID: 28986017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis - an example of personalized and precision medicine.
    Skov M; Hansen CR; Pressler T
    APMIS; 2019 May; 127(5):352-360. PubMed ID: 30761610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Genomic Medicine in Cystic Fibrosis.
    Chang EH; Zabner J
    Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis: From gene discovery to precision medicine].
    Férec C
    Med Sci (Paris); 2021; 37(6-7):618-624. PubMed ID: 34180821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
    Andersson C; Dragomir A; Hjelte L; Roomans GM
    Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Cystic Fibrosis: Clinical Implications.
    Joynt AT; Cutting GR; Sharma N
    Clin Chest Med; 2022 Dec; 43(4):591-602. PubMed ID: 36344068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane conductance regulator modulators: Present and future in cystic fibrosis treatment. A review.
    De la Hoz D; Villamil Osorio M; Restrepo-Gualteros SM
    Arch Argent Pediatr; 2019 Apr; 117(2):e131-e136. PubMed ID: 30869491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new era of personalized medicine for cystic fibrosis - at last!
    Quon BS; Wilcox PG
    Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.